• Abstractvortrag | Abstract talk
  • V085

Prävention von Spreading Depolarization assoziierter später Infarktprogression mittels Ketamin bei experimenteller Ischämie

Ketamine-induced prevention of spreading depolarization associated late infarct progression in experimental ischemia

Termin

Datum:
Zeit:
Redezeit:
Diskussionszeit:
Ort / Stream:
Gleis 5

Thema

  • Vaskuläre Neurochirurgie

Abstract

Spreading depolarizations (SD) occur frequently in patients with malignant hemispheric stroke. In animal-based experiments, SDs have been shown to cause secondary neuronal damage and infarct expansion during the initial period of infarct progression. In contrast, the influence of SDs during the delayed period is not well characterized, yet. Here, we analyzed the impact of SDs in the delayed phase after cerebral ischemia and the potential protective effect of ketamine.

Focal ischemia was induced by distal occlusion of the left middle cerebral artery in C57BL6/J mice. 24 hours after occlusion, SDs were measured using electrocorticography and laser-speckle imaging in three different study groups: control group without SD induction, SD induction with potassium chloride, and SD induction with potassium chloride and ketamine administration. Infarct progression was evaluated by sequential MRI scans.

24 hours after stroke onset we observed spontaneous SDs with a rate of 0.33 SDs/hour which increased during potassium chloride application (3.37 SDs/hour). The analysis of the neurovascular coupling revealed prolonged hypoemic and hyperemic responses in this group. Stroke volume increased even 24 hours after stroke onset in the SD-group. Ketamine treatment caused the hypoemic response to revert to a less hypoemic response and prevented infarct growth in the delayed phase after experimental ischemia.

Induction of SD with potassium was significantly associated with stroke progression even 24 hours after stroke onset. Therefore, SD might be a significant contributor to delayed stroke progression. Ketamine might be a possible drug to prevent SD-induced delayed stroke progression.